ISPUB.com / IJGO/6/1/10619
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Gynecology and Obstetrics
  • Volume 6
  • Number 1

Original Article

Trichomonas Vaginalis Infection Among Pregnant Women In South-Eastern Nigeria: The Public Health Significance

C Uneke, C Ugwuoru, E Ali, M Ali

Keywords

infection, pregnancy, prevalence, trichomonas vaginalis, trichomoniasis

Citation

C Uneke, C Ugwuoru, E Ali, M Ali. Trichomonas Vaginalis Infection Among Pregnant Women In South-Eastern Nigeria: The Public Health Significance. The Internet Journal of Gynecology and Obstetrics. 2005 Volume 6 Number 1.

Abstract

There is paucity of scientific information on the epidemiology, diagnosis and prevention of trichomoniasis among pregnant women in Nigeria. Using the spun urinalysis, a cross-sectional survey of Trichomonas vaginalis infection was conducted among married pregnant women attending antenatal clinics, for the first time in pregnancy. Of the 502 pregnant women studied, 14 (2.8%, 95% CI 1.4-4.2%) were infected with T. vaginalis. Individuals aged 20-25 years were most infected (3.7%, 95% CI 1.0-6.4%). Women in their third trimester of pregnancy were significantly more infected (8.2%, 95% CI 2.7-13.7%) (χ 2 =14.46, df=2, P<0.05), than those in their second trimester (2.3%, 95% CI 0.3-4.3%) and first trimester (0.5%, 95% CI 0.5-1.5%).The primiparae were more infected than the multiparae (6.4%, 95% CI 2.3-10.5% vs 1.4%, 95% CI 0.2-2.6%) and the difference was statistically significant (χ 2 =9.51, df=1, P<0.05). Routine surveillance of trichomoniasis among women of child bearing age and prompt treatment of infected individuals are advocated.

 

Introduction

Trichomonas vaginalis, a protozoan parasite which can be transmitted sexually, is known to be responsible for an estimated 180 million new infections per year, making it the most prevalent non-viral sexually transmitted pathogen worldwide (1). Transmission to neonates during passage through an infected birth canal is also possible (2). Although infection with T. vaginalis is frequently asymptomatic and self limited, it can however, cause urethritis in men and vaginitis in women. Vaginal discharge, vulvovaginal soreness, dysuria, dyspareunia, and/or irritation are usually experienced by symptomatic women with trichomoniasis (1). Several studies have suggested that pregnant women infected with T. vaginalis may be at increased risk of an adverse outcome. Premature rupture of membranes, premature labour, low birth weight, and post-abortion or post-hysterectomy infection are complications of trichomonal vaginitis that have been reported (3,4).

In the sub-Saharan Africa, including Nigeria, trichomoniasis has neither been the focus of intensive study nor of active control programs, and this neglect is likely a function of the relatively mild nature of the disease (5). However, in addition to the association of T. vaginalis with adverse pregnancy outcomes, increasing evidence suggests that the pathogen may serve as a cofactor in human immunodeficiency virus (HIV) transmission (6,7). Hence, the need for improved understanding of the natural history, pathology, diagnosis, treatment and prevention of this common protozoan parasite cannot be overstated.

There is paucity of information on the association of socio-demographic parameters and obstetric history with T. vaginalis infection among pregnant women in Nigeria. In this report we present the findings of a hospital-based study of the prevalence of T. vaginalis infection among pregnant women attending antenatal clinics (ANCs). The objective of the study was to provide scientific information that would improve understanding of the epidemiology of trichomoniasis among women of child-bearing age. The public health significance of results is discussed as it affects maternal health care delivery system and the prevention of T. vaginalis infection in Nigeria and other similar settings of the sub-Saharan Africa.

Methods

Study Area

The study location was Abakaliki the capital city of Ebonyi State, South-eastern Nigeria, with a population size of about 255,752. The study was conducted at the five major hospitals in the city with facility for antenatal care. The hospitals include: Ebonyi State University Teaching Hospital (EBSUTH), Holy Child Hospital and Maternity (HCHM), Felly-Sussy Memorial Hospital (FSMH), St. Theresa's Hospital and Maternity (STHM), and Mgbodo Specialist Hospital and Maternity (MSHM). Heterosexual intercourse is the predominant sexual behaviour in the area and the prevalence rates of HIV infection and syphilis among women attending ante-natal clinics (ANCs) in the area were 4.6% and 1.0% respectively (8).

Study Population /Sampling Technique

The study was conducted form January 2005 - June 2005 among pregnant women attending routine antenatal clinic at the selected hospitals. Approval for the study was obtained from the Research/Ethical Committees of the five hospitals. Approval for this study was also obtained from the Infectious Disease Research Unit of the Faculty of Clinical Medicine, College of Health Sciences, Ebonyi State University Abakaliki. The approval was on the agreement that patient anonymity must be maintained, good laboratory practice/quality control ensured, and that every finding would be treated with utmost confidentiality and for the purpose of this research only.

The study was thus, an anonymous, unlinked, cross-sectional survey and following informed consent, 502 pregnant women were enrolled into the study. All the women were married and were attending the clinics for the first time in pregnancy. Socio-demographic information and obstetric history were obtained from participants by interview. Thereafter, each subject was given a wide mouthed, leak-proof universal specimen container and was instructed on how to collect her own urine sample. About 20mls of urine sample was obtained from each participant. For the purpose of the research, no personal identifiers (names, ID number, address, etc) were used on the urine sample of the participant. Instead bar-coded numbers were used to ensure anonymity of subjects, to facilitate laboratory procedures and minimize the chances of errors during the handling of the urine specimens.

Laboratory Analysis

Microscopic examination of wet mount preparations of the urine samples was done to detect T. vaginalis using the spun urinalysis as described previously (9). Diagnosis of trichomoniasis was predicted on visualization of the organism through direct microscopy. Individuals with T. vaginalis infection were referred for medical attention.

Statistical Analysis

Differences in proportion were evaluated using the chi-square test. Statistical significant was achieved if P < 0.05.

Results

Of the total of 502 pregnant women studied, aged 20-40 years old (mean age 28.1 years), laboratory analysis confirmed T. vaginalis infection through direct microscopy in 14 (2.8%, 95% CI 1.4-4.2%) of the urine specimens. Of the five hospitals used in this study which provided the antepartum services to the subjects, the highest prevalence of T. vaginalis infection (6.9%, 95% CI 2.0-11.8%) was recorded among pregnant women at the MSHM and the least prevalence (0.9%, 95% CI 0.9-2.7%) among subjects at the STHM, although no statistically significant difference was observed (χ 2 =9.11, df=4, P<0.05) (Table 1). When age was associated with T. vaginalis infection, no significant difference was observed (χ 2 =1.37, df=3, P<0.05), although the highest prevalence of the infection was noted among individuals of age category 20-25 years (3.7%, 95% CI 1.0-6.4%) and the lowest among those aged 26-30 years old (1.9%, 95% CI 0.2-4.0%) (Table 1).

Figure 1
Table 1: Analysis of socio-demographic and obstetric history with infection among pregnant women in Abakaliki, Nigeria.

Women in their third trimester of pregnancy were significantly more infected with T. vaginalis (8.2%, 95% CI 2.7-13.7%) (χ 2 =14.46, df=2, P<0.05), than those in their second trimester (2.3%, 95% CI 0.3-4.3%) and first trimester (0.5%, 95% CI 0.5-1.5%) (Table 1).The primiparous women were more infected than the multiparous women (6.4%, 95% CI 2.3-10.5% vs 1.4%, 95% CI 0.2-2.6%) and the difference was statistically significant (χ 2 =9.51, df=1, P<0.05).

T. vaginalis infection was associated with occupation and result showed that the business women were the most infected (14.8%, 95% CI 5.3-24.3%) while the housewives were the least infected (0.9%, 95% CI 0.3-2.1%). Chi-square test indicated a significant difference in the association between occupation and infection (χ 2 =32.06, df=3, P<0.05) (Table 1). No case of T. vaginalis infection was observed among individuals with tertiary education, but women with no formal education had the highest prevalence of 6.6% (95% CI 2.2-11.0%) with a statistically significant difference (χ 2 =8.77, df=3, P<0.05).

Discussion

Antenatal screening and treatment for sexually transmitted infections (STIs) have proved beneficial in countries where the practice is adopted. However there are indications that treatment of T. vaginalis infection during pregnancy may be deleterious, probably due to metronidazole (10). This is consistent with a National Institute for Child Health and Human Development trial that found an excess of preterm births in children of women with T. vaginalis infection who were treated with metronidazole (11). Consequently the need for the prevention of T. vaginalis infection among pregnant women cannot be overstated even if the infection has not assumed epidemiological proportion in an area. The T. vaginalis infection prevalence of 2.8% observed in this study was comparatively higher than those recorded among pregnant women in Dhaka, Bangladesh (1.4%) (12) and in Bulgaria (0.9%) (13). However, in a number of other studies, the prevalence rates of T. vaginalis infection noted among pregnant women attending antenatal clinic were higher than what we observed in this study. These include the 4.7% prevalence noted in Ilorin, Nigeria (14), 16% in Mwanza, Tanzania (15), and in the USA; 12.6% in Maryland (3), 46.9% in New York (16), and 36.1% in Nebraska (17).

The prevalence of T. vaginalis infection observed in this study appeared to suggest the existence of low rate of the infection among married pregnant women. This is in conformity with a large, multicenter study of pregnant women in Maryland, USA (18), and at a primary health care ANC in Dar es Salaam, Tanzania (19), where the unmarried were significantly more infected than the married. Marital status has thus been found to be significantly associated with the level of STD preventive practices (20). However our data must be interpreted cautiously as the possibility of underestimation of the prevalence may not be completely ruled out due to our diagnostic technique. Although performing the wet mount microscopy of spun urinalysis to detect T. vaginalis is reported to be reasonably sensitive and diagnostic (9), a negative wet mount does not necessarily exclude T. vaginalis infection (21).

The wet mount microscopy is used routinely in most settings in Nigeria for T. vaginalis diagnosis, and this has an average sensitivity of 60 to 80 percent for detection of the motile T. vaginalis organisms (22). Culture of T. vaginalis using a Diamond medium, which has a sensitivity of 91 to 100 percent, is considered to be far superior to wet mount examination, however, the culture technique is more expensive than wet mount examination and requires two to seven days to obtain results (23). The sensitivity of culture when compared with polymerase chain reaction (PCR) has been estimated to be 70% (24). Such highly sensitive PCR and related techniques are neither routinely used nor readily available for T. vaginalis in Nigeria and in many parts of the sub-Saharan Africa, at least in the hospital district level. It is thus suggested that careful clinical examination and selective use of wet-mount examination together with wider use of more sensitive tests for subclinical infection, such as culture or direct immunofluorescent staining of vaginal fluid, could lead to improved detection and control of T. vaginalis infection (5).

In this study, age-related prevalence of T. vaginalis infection indicated the highest occurrence among women of 20-25 years old, although no statistically significant difference was observed (P<0.05). In a similar study in Apia, Samoa, pregnant women less than 24 years old were the most infected, and being a young pregnant woman was independently associated with current trichomonal infection (25). This was contrary to findings on the rates and risk factors for trichomoniasis among pregnant inmates in New York, USA, where a significant association was established between trichomoniasis and older age (16). The implication of this from our observation is that prevention efforts for T. vaginalis infection should be targeted at all women of child bearing age.

Nearly all the subjects classified as business women were traders and they were more infected with T. vaginalis. The reason for this outcome was somewhat obscure from this study, although a statistically significant difference was observed (P<0.05). Further studies incorporating a systematic assessment of behavioural factors associated with the sexual habits are advocated and might help to provide a better interpretation of the relationship between trichomoniasis and demographic factors such as religion and occupation.

Parity and pregnancy trimester were related to T. vaginalis infection and the risk factors associated with significant infection were primiparae and third trimester. Although infection was not associated with parity or gestational age (trimester) in a similar study in Port Moresby, Papua New Guinea (26), but Cotch et al.(3) noted that vaginal infection with T. vaginalis at mid-gestation was significantly associated with low birth weight, preterm delivery, and preterm delivery of a low birth weight infant. A randomized, controlled prospective study is therefore urgently needed to assess the extent to which, if any, trichomoniasis is related to the high perinatal morbidity and mortality from low birth weight in Nigeria.

Women with T. vaginalis infection in this investigation were significantly more likely to be less educated (P<0.05), and having no formal education was a major risk factor for trichomoniasis. This is consistent with findings of previous studies in Maryland, USA (8) and in Ilorin, Nigeria (14), where low level of education was associated with significant T. vaginalis infection among pregnant women. Therefore, there is the need for providing proper counselling and education on sexual behaviour and genital hygiene besides treatment to control and prevent trichomoniasis. Since T. vaginalis is primarily sexually transmitted, educational efforts must be aimed at high risk groups including women without any formal education and must be explicit regarding the behaviours that lead to the spread of T. vaginalis, HIV and other STIs. This is very crucial to maternal health because other vaginal infections such as bacteria vaginosis, or bacteria excess syndrome, and vaginal candida are frequent coinfections in pregnant women harbouring T. vaginalis (17,27). Given that the level of promiscuity will often be difficult to modify within a population as is commonly the case in Nigeria, then educational campaigns are best focused upon the use of barrier precautions, particularly condom use. This is very important because women using barrier precautions in the six months before becoming pregnant have been found to be far less likely to be colonized T. vaginalis (18).

In conclusion, as a public health measure, routine surveillance of trichomoniasis among women of child bearing age and prompt treatment of infected individuals are recommended. The control and prevention of trichomoniasis could also be enhanced by targeting the sexual partners of infected women for treatment and risk-reduction health education.

Acknowledgement

We wish to thank the managements of Ebonyi State University Teaching Hospital, Holy Child Hospital and Maternity, Felly-Sussy Memorial Hospital, St. Theresa's Hospital and Maternity, and Mgbodo Specialist Hospital and Maternity, all in Abakaliki, for logistical support.

Correspondence to

C. J. Uneke Department of Medical Microbiology/Parasitology, Faculty of Clinical Medicine, Ebonyi State University, PMB 053 Abakaliki, Nigeria. Tel: 234-08038928597, Fax: 234-04300222, E-mail: unekecj@yahoo.com

References

1. Petrin D, Dalgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis.
Clin Microbiol Rev 1998; 11: 300-17.
2. Danesh IS, Stephen JM, Gorbach J. Neonatal Trichomonas vaginalis infection. J Emerg Med 1995; 13: 51-54.
3. Coth MF, Pastorek JG, Nugent RP, et al.
Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 1997; 24: 353-60.
4. Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990; 163: 1016-21.
5. Wolner-Hanssen P, Krieger J, Stevens CE, et al. Clinical manifestations of vaginal trichomoniasis. JAMA 1989; 261: 571-6.
6. 6. Laga M, Manoka A, Kivuvu M, et al. Non- ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;
7: 95-102.
7. Muelen J, Mgaya HN, Chang-Claude J, et al. Risk factors for HIV infection in gynaecological inpatients in Dar Es Salaam, Tanzania, 1988-1990. East Afr Med J 1992; 69: 688-92.
8. Federal Ministry of Health Nigeria (FMHN). Technical report on 2003 National HIV/Syphilis Sentinel Survey among pregnant women attending antenatal clinics in Nigeria. Abuja: FMHN, 2004.
9. Blake DR, Duggan A, Joffe A. Use of spun urine to enhance detection of Trichomonas vaginalis in adolescent women. Arch Pediatr Adolesc Med 1999; 153: 1222-5.
10. Kigozi GG, Brahmbhatt H, Wabwire-Mangen F, et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2003; 189:1398-400.
11. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345: 487-93.
12. Begum A, Nilufar S, Akther K, Rahman A, Khatun F, Rahman M. Prevalence of selected reproductive tract infections among pregnant women attending an urban maternal and childcare unit in Dhaka, Bangladesh. J Health Popul Nutr 2003; 21: 112-6.
13. Chervenkova A, Sredkova M, Tanchev S, Plevneli B. [A clinical and microbiological study of bacterial vaginosis and vaginitis in pregnant women]. Akush Ginekol (Sofiia) 1999; 38:33-6.
14. Aboyeji AP, Nwabuisi C. Prevalence of sexually transmitted diseases among pregnant women in Ilorin, Nigeria. J Obstet Gynaecol 2003; 23: 637-9.
15. Mayaud P, Uledi E, Cornelissen J, et al. Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania. Sex Transm Infect 1998; 74 Suppl 1: S139-46.
16. Shuter J, Bell D, Graham D, Holbrook KA, Bellin EY. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis 1998; 25: 303-7.
17. Franklin TL, Monif GR. Trichomonas vaginalis and bacterial vaginosis. Coexistence in vaginal wet mount preparations from pregnant women. J Reprod Med 2000; 45:131-4.
18. Cotch MF, Pastorek JG 2nd, Nugent RP, Yerg DE, Martin DH, Eschenbach DA. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group. Obstet Gynecol 1991; 78:1087-92.
19. Mwakagile D, Swai AB, Sandstrom E, Urassa E, Biberfeld G, Mhalu FS. High frequency of sexually transmitted diseases among pregnant women in Dar es Salaam, Tanzania: need for intervention. East Afr Med J 1996; 73: 675-8.
20. O'Campo P, Deboer M, Faden RR, Kass N. Prior episode of sexually transmitted disease and subsequent sexual risk-reduction practices. A need for improved risk-reduction in-terventions. Sex Transm Dis 1992; 19: 326-30.
21. Wiese W, Patel SR, Patel SC, Ohl CA, Estrada CA. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 2000; 108: 301-8.
22. Fouts AC, Kraus SJ. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis 1980; 141:137-43.
23. Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis: comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988; 259: 1223-7.
24. Madico G, Quinn TC, Rompalo A, McKee KT. Jr, Gaydos, CA. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36: 3205-10.
25. World Health Organization (WHO). Antenatal Clinic Sti Survey Apia, Samoa. Ministry of Health, Samoa. Western Pacific Regional Office -World Health Organization , 2000.
26. Klufio CA, Amoa AB, Delamare O, Hombhanje M, Kariwiga G, Igo J. Prevalence of vaginal infections with bacterial vaginosis, Trichomonas vaginalis and Candida albicans among pregnant women at the Port Moresby General Hospital Antenatal Clinic. P N G Med J 1995; 38: 163-71.
27. Audisio T, Penacino M, Cannistraci R, Bertolotto P. Detection of bacterial vaginosis, Trichomonas vaginalis infection, and vaginal Candida infection: a comparative study of methods of extracting exudates, with and without a speculum, during pregnancy. J Low Genit Tract Dis 2005; 9: 213-5.

Author Information

Chigozie J. Uneke, M.Sc.
Department of Medical Microbiology/Parasitology, Faculty of Clinical Medicine, Ebonyi State University

Cletus D. C. Ugwuoru, B.Sc.
Department of Medical Microbiology/Parasitology, Faculty of Clinical Medicine, Ebonyi State University

E. Ali, AIMLS
Department of Medical Microbiology/Parasitology, Faculty of Clinical Medicine, Ebonyi State University

Mirian Ali, B.Sc.
Department of Medical Microbiology/Parasitology, Faculty of Clinical Medicine, Ebonyi State University

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy